Top 50 Health Care VC Funds & Investors in Germany (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
133 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Biotechnology, Information Technology | $790k–$31M |
|
IBB Ventures
VC Fund
|
46 | Germany, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Health Care, SaaS | $1M–$11M |
|
Bayern Kapital
VC Fund
|
41 | Germany, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, Manufacturing | $1.7M–$132M |
|
Atlantic
VC Fund
|
36 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Health Care, Artificial Intelligence | $850k–$30M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
27 | Germany, United States | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Health Care | $796k–$15M |
|
Think.Health
VC Fund
|
24 | Germany, United States, France | Seed, Series A, Series B | Health Care, Biotechnology, Medical Device | $1.1M–$28M |
|
Calm/Storm VC
VC Fund
|
24 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
NRW.BANK
VC Fund
|
23 | Germany, United States, France | Seed, Series A, Pre-Seed | Software, Biotechnology, Information Technology | $209k–$36M |
|
HV Capital
VC Fund
|
22 | Germany, United States, United Kingdom | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.5M–$80M |
|
DvH Ventures
VC Fund
|
21 | Germany, Austria, United Kingdom | Seed, Series A, Series B | Health Care, Software, Financial Services | $1M–$30M |
|
KfW
VC Fund
|
21 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Wellington Partners
VC Fund
|
19 | Germany, United States, United Kingdom | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.1M–$100M |
|
Antler
VC Fund
|
19 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
APX
VC Fund
|
19 | Germany, United Kingdom, United States | Pre-Seed, Seed, Series A | Software, SaaS, Artificial Intelligence | $55k–$15M |
|
b2venture
VC Fund
|
18 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.2M–$52M |
|
Rheingau Founders
VC Fund
|
17 | Germany, United States, Poland | Seed, Series A, Pre-Seed | Software, E-Commerce, Internet | $627k–$14M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
17 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
17 | Germany, United States | Seed, Series A | Software, Health Care, Information Technology | $461k–$10M |
|
bmp Ventures
VC Fund
|
17 | Germany, United States, Austria | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Manufacturing | $162k–$12M |
|
Brandenburg Kapital
VC Fund
|
16 | Germany, United Kingdom | Seed, Series A, Venture - Series Unknown | Health Care, Software, Information Technology | $873k–$13M |
|
Heal Capital
VC Fund
|
16 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Software | $1M–$35M |
|
MIG Capital
VC Fund
|
15 | Germany, France, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Software | $1.7M–$60M |
|
Saarbruecker 21
VC Fund
|
15 | Germany, United States, Israel | Seed, Pre-Seed, Angel | Software, Internet, E-Commerce | $267k–$5.9M |
|
IFB Innovationsstarter
VC Fund
|
14 | Germany, United States, Switzerland | Seed, Grant, Series A | Software, SaaS, Artificial Intelligence | $79k–$67M |
|
BayBG Venture Capital
VC Fund
|
13 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $732k–$21M |
|
Ananda Impact Ventures
VC Fund
|
13 | Germany, United Kingdom, Finland | Seed, Series A, Series B | Health Care, Software, Information Technology | $1.6M–$53M |
|
redalpine
VC Fund
|
12 | Germany, Switzerland, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Health Care, Biotechnology | $1.6M–$125M |
|
YZR Capital
VC Fund
|
12 | Germany, United Kingdom, Poland | Seed, Pre-Seed, Series A | Health Care, Medical, Artificial Intelligence | $742k–$52M |
|
seed + speed Ventures
VC Fund
|
12 | Germany, Austria, Switzerland | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $625k–$20M |
|
Auxxo
VC Fund
|
12 | Germany, United Kingdom, France | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $1.1M–$14M |
|
BioMedPartners
VC Fund
|
11 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5.3M–$75M |
|
Vorwerk Ventures
VC Fund
|
11 | Germany, United Kingdom, Denmark | Seed, Series A, Series B | E-Commerce, Health Care, Software | $3.3M–$80M |
|
468 Capital
VC Fund
|
11 | United States, Germany, Singapore | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$42M |
|
Heartcore Capital
VC Fund
|
11 | United States, Denmark, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1.2M–$58M |
|
Springboard Health Angels
VC Fund
|
11 | Germany, United States, Switzerland | Seed, Pre-Seed | Health Care, Medical, Software | $400k–$5.8M |
|
Creathor Ventures
VC Fund
|
10 | Germany, Switzerland, United States | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$30M |
|
Cherry Ventures
VC Fund
|
10 | Germany, United Kingdom, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $1.1M–$44M |
|
TechVision Fund
VC Fund
|
10 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $1.2M–$28M |
|
Picus Capital
VC Fund
|
10 | United States, Germany, United Kingdom | Seed, Series A, Pre-Seed | Software, Financial Services, FinTech | $563k–$34M |
|
Target Global
VC Fund
|
10 | Germany, United States, Israel | Series A, Seed, Series B | Software, FinTech, Financial Services | $2M–$100M |
|
coparion
VC Fund
|
9 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
Capacura
VC Fund
|
9 | Germany | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Recycling, Software | $505k–$2.9M |
|
Flixfounders
VC Fund
|
9 | Germany, Israel, Luxembourg | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $543k–$34M |
|
better ventures
VC Fund
|
9 | Germany, Switzerland, Luxembourg | Pre-Seed, Seed, Venture - Series Unknown | Health Care, Software, Manufacturing | $1.1M–$6.9M |
|
Redstone.VC
VC Fund
|
9 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
Earlybird Venture Capital
VC Fund
|
9 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.5M–$75M |
|
BONVENTURE
VC Fund
|
9 | Germany, Austria, Estonia | Seed, Series A | Health Care, Software, SaaS | $980k–$19M |
|
Amino Collective
VC Fund
|
8 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
MediVentures
VC Fund
|
7 | Germany | Seed, Series A, Venture - Series Unknown | Wellness, Health Care, Biotechnology | $2.3M–$17M |
|
Andera Partners
VC Fund
|
7 | France, United States, Germany | Series B, Private Equity, Series A | Biotechnology, Health Care, Medical | $10M–$237M |
| Access all 1712 VC funds in Germany Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 771
- Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Extoll — EXTOLL, a leader in high-speed, ultra-low power SerDes and Chiplet connectivity, offers semiconductor IP with the smallest footprints and highest PPA. Serving global ASIC, SoC, and Chiplet markets, our portfolio includes tailored NoC (Network-on-Chip) and Die-to-Die solutions. EXTOLL drives innovation, enabling successful migration into the Chiplet Age.
- BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
- CenterPoint - Connective Software Engineering — CenterPoint was founded in 2000 and is based in Villach, Austria with an additional office in Warsaw, Poland. CenterPoint - Connective Software Engineering develops and markets process control and fault detection and classification software solutions. The company offers cause effect analysis, metrology assessment, and close loop and run to runcontrol services. It's focus are the semiconductors, electronics, and steel and alloy industries.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 266
- Round size: Seed $1M–$4.6M; Series A $2.3M–$11M; Venture - Series Unknown $2.7M–$8.4M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
- Jurafuchs — Jurafuchs provides legal education via a mobile app.
- Amara — Voice-first senior companion delivered via tablet and dock with a family app, serving Germany's AgeTech market.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 259
- Round size: Seed $1.7M–$6.3M; Series A $3.9M–$32M; Series B $3.9M–$132M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $29M in 2010
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Arcos — Arcos is a civil safety and security technology company.
- HyImpulse Technologies — HyImpulse develops dedicated sub-orbital and orbital launch services using hybrid propulsion-based launch vehicles. Their SR75 is a single stage sounding rocket using a hybrid rocket engine to deliver institutional and commercial experiments into a micro gravity environment during a suborbital flight.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 272
- Round size: Seed $1.1M–$9.4M; Pre-Seed $850k–$3.5M; Series A $4.5M–$30M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Phase0 — Payment platform for construction projects
- Lightspring — Lightspring is a photonics technology company developing advanced 3D optical interconnection solutions for photonic systems.
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, United States
Investor stats
- Total investments: 159
- Round size: Seed $796k–$4.8M; Series A $1.9M–$15M; Venture - Series Unknown $2.3M–$5.8M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Prodlane — Prodlane, the company behind MAIA, is a technology company based in Leipzig that specializes in intelligent software solutions for SMEs in the DACH region. With MAIA, we are setting new standards in data analysis and daily knowledge management in all areas of the company using AI, thereby driving forward the digital transformation of SMEs.
- Cyber Insight — Cyber Insight - Measure, Manage, Mitigate Cyber Risks
- HandsOn Robotics — Handson Robotics provides state of the art robotics automation workflows for commercial kitchens.
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 36
- Round size: Seed $1.1M–$7.6M; Series A $3.8M–$28M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
- Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 144
- Round size: Seed $1.3M–$6.3M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
- Health Force — Health Force develops AI agents that automate administrative and front-desk workflows for hospitals and clinics.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, France
Investor stats
- Total investments: 138
- Round size: Seed $219k–$7.7M; Pre-Seed $209k–$2.1M; Series A $2.4M–$36M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $163M in 2023
Portfolio highlights
- syte — syte simplifies real estate decisions with AI-based software. Founded in 2021 and based in Münster, Germany, the company analyzes land and buildings in real time and makes complex real estate analyses easily accessible. The syte platform offers digital twins by intelligently linking various types of data, including cadastral and LiDAR data, aerialand satellite images, and market data. The database enables informed statements to be made about development opportunities, renovation potential, energy requirements, economic efficiency, and subsidy options.Project developers, real estate agents, and banks use syte for valuations, planning, and consulting. This includes evaluating locations, reviewing investment decisions, analyzing portfolios with regard to renovation needs, and identifying subsidies. Instead of time-consuming individual research or external expert opinions, the platform enables a reliable initial assessment.The team of over 30 people led by founders Matthias Zühlke and David Nellessen serves over 200 customers – from local real estate agencies to banks with thousands of properties. syte has received multiple awards for its innovative software, including the German AI Award 2023 and the PropTech of the Year Award 2025.
- Nunos — NUNOS develops biological treatment systems that convert livestock slurry into liquid fertilizer and recycle nitrogenous wastewater.
- OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
HV Capital is one of the leading early-stage and growth investors in Europe. With nine fund generations in 23 years and €2.8 bn in managed assets, HV Capital is one of the continent's most active investors. The investment team has many years of experience in identifying European startups with great potential for success. In addition tointernational success stories like Zalando, Delivery Hero, Sumup, and Depop, innovation leaders such as Enpal, Flixbus, Sennder, and Isar Aerospace are also part of the portfolio. HV Capital has invested in around 225 internet and technology companies, supporting startups with ticket sizes ranging from €0.5 to €60m. It is one of Europe's few venture capital firms that can finance startups through all growth phases. HV Capital has a team of more than 40 investment and operations professionals who provide a variety of perspectives and expertise across the venture capital landscape.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 508
- Round size: Seed $1.5M–$12M; Series A $3.6M–$37M; Series B $7.5M–$80M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $783M in 2023
Portfolio highlights
- Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
- Flip — The AI employee experience platform for frontline workers without a company email. Flip unites comms, HR, identity and AI in one app. Book a demo.
- Ore Energy — Ore Energy is creating a new generation, cost effective, long-duration energy storage solution which will enable a decarbonized energy future by utilizing some of the most readily available materials
Investing early in Europe's most passionate founders.
Show more...Investment focus
- Industry: Health Care, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 107
- Round size: Seed $1M–$7.9M; Series A $3.9M–$19M; Series B $4.7M–$30M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $70M in 2020
Portfolio highlights
- Dermanostic — Dermanostic is an e-health app where patients receive a medical diagnosis and therapy recommendation for skin diseases.
- Dr. Vivien Karl — Dr. Vivien Karl is an intimate care company. Dr. Vivien Karl provides science based products for effective and safe intimate care. Their products include cream for moisturizing and caring for the intimate area.
- microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 162
- Round size: Series A $2.2M–$7.5M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — Empowering a sustainable digital society by enabling infrastructure where it is needed.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 221
- Round size: Series A $3.1M–$36M; Series B $8.3M–$65M; Series C $5.5M–$100M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $233M in 2019
Portfolio highlights
- nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Founded to serve patients through transformative medicines
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2382
- Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
- myluigi.ai — Luigi is an AI-Powered Full-Stack Game Growth-as-a-Service platform designed to help mobile game studios scale user acquisition, engagement and lifetime value without adding headcount. Its dual-engine architecture automates and operates everything from ad campaign creation and real-time creative optimization to personalized in-game offers and LTVforecasting—delivered through a single, easy-to-integrate and unified dashboard. With a flexible per-title pricing model and powerful machine-learning insights, Luigi empowers mid-sized and indie developers to reduce CPI, boost retention and chart a clear path toward sustainable growth and seven-figure ARR.
- RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
APX is Europe’s leading very-early-stage VC. Based in Berlin and backed by Axel Springer and Porsche, we support and partner with the most ambitious founding teams from Europe and beyond - often as their first investor.We invest up to EUR 500K in startups until a series A starting with a quick EUR 50K investment, and within a few months,depending on traction and speed, we can invest further. Each month we invest in new teams who become part of the APX community, counting hundreds of other founders. Since 2018, we have invested in 100+ startups across 20+ industries with founders from 20+ countries together with 100+ co-investors.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 211
- Round size: Seed $1M–$5M; Pre-Seed $55k–$1.4M; Series A $2.1M–$15M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $67M in 2021
Portfolio highlights
- VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
- Bloom — Moved to @bloomsocial
- Track Titan — Titan Academy revolutionises how gamers improve through fully automated coaching.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 278
- Round size: Seed $1.2M–$8.8M; Series A $3.4M–$23M; Series B $6.9M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2026
Portfolio highlights
- LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
- Everlab — The preventative health service of the future. Detect disease early, improve wellbeing, and optimise performance.
- Flyboard — Human-level AI voice agents at a fraction of the cost. Transform your customer engagement with intelligent automation.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 89
- Round size: Seed $627k–$6.3M; Pre-Seed $770k–$2.7M; Series A $2.7M–$14M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
- Akhetonics — Akhetonics is a photonic computing company building all-optical processors for ultra-fast AI and high-performance computing. It is a deep-tech semiconductor company focused on photonic (light-based) computing hardware. It develops all-optical processors designed to accelerate AI, reasoning, and complex computational workloads. The company aims todeliver ultra-fast, energy-efficient computing beyond traditional electronic chips.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 108
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 72
- Round size: Seed $461k–$3.3M; Series A $1.2M–$10M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- warmwind — warmwind is your all in one solution, when it comes to AI workers. No more tool chaos - everything in the cloud.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 122
- Round size: Seed $162k–$3.6M; Series A $912k–$5.9M; Venture - Series Unknown $172k–$12M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $70M in 2024
Portfolio highlights
- Lab Thunder — LabThunder provides a cloud-based laboratory management software platform designed to digitize operational workflows. The system centers on centralizing equipment management, automated maintenance scheduling, digital logbooks, and AI-supported knowledge management to ensure audit-ready compliance.
- Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
- Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $873k–$6.1M; Series A $2.8M–$13M; Venture - Series Unknown $1.1M–$7.5M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
- All About Accuracy — Sub-1mm accuracy and <1ms latency RF localization for physical AI. Train robots with ground-truth motion data cameras and GPS can't reach.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 51
- Round size: Seed $1M–$12M; Pre-Seed $1.9M–$4M; Series A $3.7M–$35M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
- Tokura — Tokura focused on redesigning outpatient surgery (Ambulantes Operieren) through an integrated system of specialised facilities, experienced teams, and automated technology.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Series A $1.9M–$40M; Series B $1.7M–$60M; Venture - Series Unknown $5.6M–$20M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
They are a group of friends and internet/tech entrepreneurs who first met ten years ago in Saarbruecker Strasse 21 in Berlin Prenzlauer Berg. All of them started successful businesses, they are founders and share a passion for building great companies. As active business angels, they also invest in young startups, either individually orcollectively as a group. They provide seed funding for killer-founders and great ideas. But way more important: they help to avoid mistakes that they have already made . They introduce to the right people. They provide with all the experience that they have. Not just talking about it but helping hands-on.
Show more...Investment focus
- Industry: Software, Internet, E-Commerce
- Stage:Seed, Pre-Seed, Angel
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 87
- Round size: Seed $267k–$5.9M; Pre-Seed $542k–$1.6M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Meine Erde — Meine Erde is a provider of ecological burial option in Europe.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant, Series A
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 90
- Round size: Seed $365k–$3M; Grant $79k–$178k; Series A $1.7M–$67M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $16M in 2023
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- eleQtron — eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 118
- Round size: Series A $1.2M–$6.4M; Series B $732k–$21M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- CONXAI — AI that understands construction
- SPiNE — SPiNE is a startup that provides safe, clean, and inexpensive energy to all end users. It is focused on smart meter rollout and, as a result, digitalization in metering and control of charging infrastructure, heat pumps, and battery storage.
- TalentRocket — Talent Rocket is a job search engine that enables its users to find jobs with a suitable work environment for them. Job seekers can select their preferred company culture, follow their favorite companies, and start career conversations with employers. Talent Rocket was founded in 2014 and is based in London, United Kingdom.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 73
- Round size: Seed $1.6M–$18M; Series A $3.9M–$17M; Series B $7.3M–$53M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $85M in 2026
Portfolio highlights
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
- Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
- Entelo Bio — Precision Medicine
redalpine is a thesis-driven vc with deep expertise in software and science. since 2006. we believe in the power of big ideas and in empowering game changers. we don't just invest, we co-create a better tomorrow. together with you.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 203
- Round size: Seed $1.6M–$13M; Series A $3.2M–$33M; Series B $16M–$125M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $200M in 2024
Portfolio highlights
- telli — A world where every interaction is worth having. https://t.co/Qa65ENaxKL
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
- Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Poland
Investor stats
- Total investments: 37
- Round size: Seed $2.5M–$5.5M; Pre-Seed $742k–$2.5M; Series A $10M–$52M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $105M in 2022
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 87
- Round size: Seed $1.3M–$5.8M; Pre-Seed $625k–$3.9M; Series A $2.5M–$20M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $107M in 2026
Portfolio highlights
- Covalo — Covalo™ is disrupting how formulation-driven products are developed in the 3 trillion euro consumer goods industry so brands can reduce time to market by scouting ingredients and packaging, collaborating on projects, and purchasing -- all from one place. . Today it's one of the largest beauty ingredient search platforms that connects beautybrands with suppliers of ingredients, packaging, and services such as contract manufacturing, formulation, regulatory, compliance and testing. It also arms suppliers with the tools and real-time industry insights needed to effectively market products. Covalo launched in 2021 and is based in Switzerland.
- SOUS — One easy-to-use tool to grow traffic, make online sales, seamlessly handle orders and drive retention. Built for food entrepreneurs, built with taste.
- Promptwatch — PromptWatch is a platform designed for SEO professionals and digital marketers who want to stay ahead in the age of AI-driven search. As Generative AI engines like ChatGPT, Claude, and Perplexity increasingly influence how users discover information, PromptWatch helps businesses ensure their brand is visible and relevant within these AI-generatedanswers. Our tool enables users to monitor mentions of their brand across leading AI engines, uncover where and how their business is referenced, and identify optimization opportunities to improve visibility. By tapping into Generative Engine Optimization (GEO), PromptWatch empowers marketers to adapt their strategies beyond traditional search engines—ensuring their content gets surfaced in the conversations and answers that matter most. PromptWatch is your essential toolkit for thriving in the next wave of search.
The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female-(co-)founded startups in Europe.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 50
- Round size: Seed $2.1M–$7.5M; Pre-Seed $1.1M–$2.9M; Series A $6M–$14M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $30M in 2025
Portfolio highlights
- NanoStruct — NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and pathogens in food.
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 88
- Round size: Series A $5.3M–$31M; Series B $5.3M–$75M; Series C $5.3M–$47M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $106M in 2018
Portfolio highlights
- T-CURX — T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges ...
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Backing early-stage startups that drive positive impact for people and planet
Show more...Investment focus
- Industry: E-Commerce, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Denmark
Investor stats
- Total investments: 92
- Round size: Seed $3.3M–$12M; Series A $5.6M–$35M; Series B $11M–$80M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $152M in 2022
Portfolio highlights
- Averia — Averia is focused on geotechnical and environmental engineering. The company supports businesses in geotechnical engineering, hydrogeology, environmental technology.
- AssistMe — With a smart, adaptive and automated form of data processing and preparation, alea opens the way for future-proof, digitally supported everyday care. As an initial component of the AssistMe care platform, alea enables a contemporary, efficient care data culture for future intersectoral, networked processes and digitally supported teamwork. In theend, the aim is to effectively support care in times of a shortage of skilled workers through more self-determined content transparency - with complete personal autonomy and freedom of action and less redundancy & stress.Elderly Care will struggle in the next 10 years due to an increasing ageing population, fewer caregivers, more workload, stress, and manual documentation. All of that is a problem for the well-being of those in need of care. Furthermore, the incontinence management means large time and material expenses for caregivers. With the joint system, both companies can equip over 80 % of care recipients in care homes. An initial scientific study proved that the system could save 23 % of adult diapers and time while changing them. Together with significantly fewer leakages, the caregiver can reinvest the time gained in even higher quality care work. This ultimately has the potential to benefit care recipients in terms of quality of sleep and life. Digital functions for optimized care processesWith a very new smart sensor strip, we made leading quality adult diaper brands compatible with the digital possibilities of intelligent care technology of alea. The system reveals where care needs exist, but are not immediately visible, e.g. the urine status in the adult diaper which previously was not known until manually checked. The system transforms this initially hidden care and health data and converts it into digital, structured, immediately understandable real-time information for elderly care and its relevant stakeholders. All functionalities are based on the device alea sensor clip on smart Diaper products, which can be attached and changed in seconds. With just one quick click, caregivers turn the smart diaper into a ready-to-use digital care assistance system. With an optimal sensor position in the centre of the adult diaper and without direct skin contact. The alea hardware can generate highly valid information and make it available to care staff in real time through the mobile and web apps. The care-relevant information of alea includes the amount of urine, movements in the care bed for effective pressure ulcer prevention, fall detection and zone management. How caregivers, care homes & care recipients benefitOver 80 % of care home residents suffer from incontinence. This is a major challenge for everyone involved. The smart system solves issues for all care related audiences: Care recipients benefit from less time in full incontinence pads, but also benefit from fewer manual visual checks during bedtimes. In addition, there is a higher level of safety and prevention. By reducing time-consuming routine and visual checks on an as-needed basis. Caregivers can invest the time gained in other important or relevant care tasks. In this way, they can increase their self-determination in their work and thus their job satisfaction. Thanks to the significant savings in materials and costs, care home operators gain more planning security and can focus their business value creation even better on direct care for people in need of care. In this way, care homes can position themselves as more attractive employers for care staff because they have state-of-the-art digital equipment.With the Care. For the Care. The solution was developed and tested together with the care practice. With the IoT and future-proof platform approach, caregivers will benefit from additional functions in an established and accepted product setting. The system can be connected to various care documentation systems via open interfaces. The aim of the solution is not only to reduce the workload for all those involved in care. Care homes can also optimize teamwork and automate routine processes to support caregivers in the interests of people-centric care in the face of an increasing shortage of skilled staff. With the market entry, care homes can obtain information and order from us or one of our partners. While they order smart Diapers from our partners in the unit price context they are used to, alea Digital System comes as a software-as-a-service model. Without any additional initial costs, they can use all functions via personally provided hardware and software for each care recipient – for the most cost-efficient and needs-orientated use.
- Reformer Club — Reformer Club creates aesthetically designed studios for dynamic Reformer Pilates and personal training that make movement part of your lifestyle.
468 Capital is an investment firm that focuses on identifying and managing opportunities in various markets. The firm employs a systematic approach to investment analysis and portfolio management. It collaborates with a range of partners to support its investment strategies. The company serves industries including technology, healthcare, andrenewable energy.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, Singapore
Investor stats
- Total investments: 229
- Round size: Seed $2.3M–$12M; Pre-Seed $500k–$3.8M; Series A $9M–$42M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $400M in 2022
Portfolio highlights
- Relixir — Relixir is AI Generative Engine Optimization (GEO) assistant that maps, monitors and improves AI search rankings.
- Pally — Pally is an AI personal assistant you text. Use it on iMessage, Android RCS, or Telegram for email, calendar, reminders, research, and errands.
- ARC Intelligence — ARC Intelligence operates as a supplier of data systems driven by AI for small and medium-sized businesses.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, Germany
Investor stats
- Total investments: 217
- Round size: Seed $1.2M–$11M; Series A $3.4M–$27M; Series B $9.5M–$58M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2024
Portfolio highlights
- Davis AI — Davis AI provides AI-driven real estate development services focused on early-stage feasibility studies and architectural design. The company combines proprietary generative models, including its Gaudi-1 architectural generation model, with in-house architects to deliver site analysis, regulatory diagnostics, volumetrics, financial modeling, andinvestment analysis. Davis AI also produces architectural outputs such as floor plans, unit mix optimization, and space planning. Its workflow ingests client data rooms and enriches them with regulatory, market, and site data, turning these into constraints that guide every result. Outputs are refined and validated by human experts before delivery and are intended for real estate developers, investors, and other project stakeholders.
- Fora — Fora's expert travel advisors will help you plan your dream trip while unlocking exclusive perks and upgrades. Welcome to the modern travel agency.
- PhaseTree — Materials design simulation company - PhaseTree ApS
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 25
- Round size: Seed $932k–$5.8M; Pre-Seed $400k–$3.8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Cellbyte — Turn weeks of manual research into answers in minutes. Powered by AI agents, backed by experts.
- MedGlance AI — MedGlance AI is a pioneering HealthTech platform that transforms complex medical reports into intuitive, patient-friendly visual protocols. Utilizing advanced Generative AI and the NanoBanana 2 (gemini-3-flash) engine, we provide real-time anatomical visualizations to improve health literacy and patient outcomes. Our "Zero-Retention"protocol ensures total data privacy, making us a trusted partner for healthcare providers and individual patients alike. We are dedicated to ensuring Health Equity through accessible, visual-first medical communication
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Round size: Seed $1.1M–$7.7M; Series A $2M–$12M; Series B $5.1M–$30M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $90M in 2016
Portfolio highlights
- HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 297
- Round size: Seed $1.9M–$14M; Pre-Seed $1.1M–$6.6M; Series A $7.3M–$44M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $500M in 2025
Portfolio highlights
- Resolutiion — Resolutiion provides AI-powered software for managing commercial conflict, delivery risk, and business relationship performance. The platform supports organizations with dispute detection, workflow automation, contract monitoring, issue resolution, and operational risk management across customers, suppliers, workforce teams, and commercialpartnerships. Its system uses AI-driven analysis to identify relationship friction, monitor delivery performance, and support structured resolution processes. Resolutiion also provides commercial intelligence tools, reporting, and collaboration features for enterprise delivery and governance management.
- Spiich Labs — AI for revenue teams that win on relationships. The agentic sales platform that eliminates CRM admin: your CRM updates itself after every call, you get daily meeting briefs, and follow-ups write themselves. Save 9+ hours weekly.
- Integral — Bookkeeping, financial statements, and payroll all from one source
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 43
- Round size: Seed $1.5M–$5.8M; Pre-Seed $1.2M–$2.4M; Series A $5.4M–$28M
- Lead/follow: 70% lead, 30% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Octonomy — octonomy: AI-as-a-Service mit der neuen Generation von KI-Agenten. 80 % Zeitersparnis, 24/7-Support in 30+ Sprachen, live in 20 Tagen.
- Wakeline — Wakeline builds the missing half of AI: continual learning that adapts in operation, staying aligned as conditions change. Market Edge delivers adaptive day-ahead price forecasts for European BESS operators.
- Eeden — Eeden engages in the manufacture and supply of textiles.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 452
- Round size: Seed $1.6M–$11M; Pre-Seed $563k–$4.5M; Series A $3.9M–$34M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Enpal — Kostenlose Planung von Solaranlagen. Gewinnbringende & schnelle Umsetzung von Photovoltaikanlagen inklusive professionelle Installation & Netzanschluss. Zum Festpreis!
- Lightbase — An always up-to-date view of your entire IT ecosystem for faster decisions and confident transformation at scale
- Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...
Target Global is a prominent European technology investment firm with a significant presence in the venture capital landscape, boasting over €3 billion in assets under management. The firm operates out of key tech hubs including London, Berlin, Tel Aviv, and Abu Dhabi, and has a rich portfolio featuring some of Europe's most successful techcompanies such as Revolut, Auto1, Copper, Delivery Hero, Docplanner, and Rapyd.Founding and GrowthTarget Global was established in 2015 by Shmuel Chafets and Yaron Valler, who brought a wealth of experience from their tenure at Hasso Plattner Ventures. Their professional partnership dates back 15 years to their time at Giza Venture Capital, a trailblazer in Israel's investment ecosystem, where they honed their investment acumen and industry foresight.Investment Philosophy and ImpactTarget Global stands out in the European tech industry for its diverse team and its ability to identify and capitalize on unique opportunities. The firm's knack for recognizing potential in the early stages of Germany's tech economy led to the emergence of several unicorns in the 2010s. As the European tech industry evolves, Target Global remains at the forefront, seeking out innovative companies like Robovision, Saleor, and Finom. These recent investments reflect the firm's commitment to supporting cutting-edge technology and business models.Fundraising SuccessesTarget Global's fundraising prowess is evident in its six investment funds, which have collectively raised significant capital. The funds range from Early Stage Funds, focusing on nascent startups, to Growth Funds that support more mature companies scaling their operations. The firm's co-investment strategy has led to over €1 billion in capital deployment across a diverse array of partnerships.Backing and AchievementsWith the backing of investors such as FERI, UBS, Allianz X, Mubadala, and Hermes GPE, Target Global has cemented its reputation as a trusted and successful investment firm. Its portfolio spans over 140 companies at various development stages, with a focus on those targeting trillion-dollar markets.Just a few of the many notable companies in the firm’s portfolio include:- Tarabut, MENA’s leading open banking platform, which was recently featured in Forbes Middle East’s list of Top 50 Fintech Companies.- Flo Health, an AI-driven women’s health product, which is the world’s top health and fitness app by downloads.- Robovision, an easy-to-use AI-driven computer vision platform for users to develop their own deep-learning-based solutions.- Enter, a German company that helps homeowners and businesses reduce their carbon footprint.Target Global's track record includes support for 15 unicorn companies, over 20 exits, and 7 IPOs, showcasing its ability to drive growth and success in the European tech ecosystem. The team, comprised of individuals with founder and operator backgrounds, continues to pursue exceptional opportunities to expand the firm's portfolio and influence.Target Global's journey from its inception to its current status as a key player in European venture capital is marked by strategic investments, a commitment to diversity, and a deep understanding of the tech industry's dynamics. With a clear vision for the future, Target Global is poised to continue its role in shaping the next wave of European tech giants.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 246
- Round size: Seed $2M–$19M; Series A $3.8M–$34M; Series B $11M–$100M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $214M in 2022
Portfolio highlights
- Alta — Alta leverages data and AI to drive business growth 24/7.
- Nimble Way — Automate data collection with real-time pipelines. Power AI & BI with structured, cloud-integrated data for accurate insights & growth.
- Health Force — Health Force develops AI agents that automate administrative and front-desk workflows for hospitals and clinics.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more...Investment focus
- Industry: Health Care, Recycling, Software
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 26
- Round size: Seed $505k–$2.9M; Pre-Seed $889k–$963k
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- odacova — Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms.
- Foom — The foom technology extracts valuable fertiliser from organic waste - on site and in record time
- Everwave — Everwave is a social enterprise that focuses on preventing plastic pollution in rivers and oceans.
Flixbus' founders' family office
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, Luxembourg
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$15M; Pre-Seed $543k–$3.8M; Series A $8.5M–$34M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Augur — Augur provides advanced sensor fusion and machine learning solutions for security applications.
- R3 Robotics — Circu Li-ion is a European battery upcycling startup. Our vision is to fight the climate crisis by maximising the lifecycle of each Lithium-ion cell.In 2021, we have embarked on our journey to enable a circular lifecycle to batteries in three steps: the dismantling of batteries, the diagnostic of cells and the reassembly based on reusedcomponents - automated and at scale .We provide our technology to leading players in the space of micromobility, q-commerce & delivery, hardware manufacturing and recycling. Our Machine-as-a-Service solution offers a possibility to give their used batteries a second life through upcycling instead of recycling - saving money and the planet.
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
At better ventures we invest in early-stage founders who aim to change our world for the better.
Show more...Investment focus
- Industry: Health Care, Software, Manufacturing
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Germany, Switzerland, Luxembourg
Investor stats
- Total investments: 55
- Round size: Seed $1.5M–$6.9M; Pre-Seed $1.1M–$3M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
- Enzo — Enzo is a Heidelberg based InsurTech startup offering modern and smart insurance coverage for homeowners. Instead of just reacting to claims, Enzo takes a proactive customer-focused approach to prevent damages from happening at all. Thus, Enzo is leading a paradigm shift in a €100+ billion market that has barely improved customer experience forover 100 years. Our Goal is to become Europe's smartest homeowners insurance.
- Cotierra — Biochar made from agricultural residues in the tropics can become a gamechanger for farmers and climate change mitigation
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 179
- Round size: Seed $460k–$7.8M; Pre-Seed $1M–$4.4M; Series A $1.7M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $29M in 2026
Portfolio highlights
- FermLabs — Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms.
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
Founded in 1997, Earlybird is a pan-European VC investor backing tech-enabled companies and investing in their growth and development. Funds include Earlybird, Earlybird Health, Growth Opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 401
- Round size: Seed $1.5M–$14M; Series A $3.5M–$35M; Series B $6M–$75M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $422M in 2026
Portfolio highlights
- Avrea — Avrea is the CI/CD platform built for the age of AI, helping teams ship software faster, more often, and with higher quality.
- ColibrITD — ColibriTD leader of Simulation solutions using Quantum computing
- TRAKKER — TRAKKER turns real-world visitor behavior into live analytics, lead intelligence, and personalized event journeys. For organizers, exhibitors, and visitors.
BONVENTURE empowers impact-driven founders and impact investors across DACH with capital, expertise, and a strong network for true impact and return.
Show more...Investment focus
- Industry: Health Care, Software, SaaS
- Stage:Seed, Series A
- Geography: Germany, Austria, Estonia
Investor stats
- Total investments: 46
- Round size: Seed $980k–$11M; Series A $5.1M–$19M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $55M in 2022
Portfolio highlights
- BIOWEG — Founded in Germany in 2019, Bioweg is a purpose-driven company, matches BioInnOvation to business problems. Their research combine biotechnology, material science, and molecular simulation learning to develop and sell B2B advanced sustainable and bio-based high-performance ingredients. Their ingredients are 100% animal-free, globally scalable, andsustainably manufactured with green chemistry. The company partners with results-driven, forward-thinking companies and consumer brands with global reach in cosmetics, personal care, agricultural technology, and food/beverage sectors. Bioweg's innovative zero-waste circular process uses food industry waste as feedstock to produce bio-based microbeads, rheology modifiers and hydrocolloids that are completely free of microplastics and comply with the new ECHA regulation.
- Resourcify — Resourcify is on a mission to enable a zero-waste future!!! Through the digitisation of daily operations, our recycling platform enables all businesses to manage, track, and improve their recycling while having less administration, and saving up to 40% of the costs compared to conventional waste management.Resourcify is trusted by thousands ofthe most leading companies & organisations around the globe including : Cargill, McDonalds, Hornbach, Johnson & Johnson, Edeka, Frankfurt Airport, UK Bonn, and more! Our award-winning recycling platform improves the approach to sustainability as a best practice and enhances the recycling processes to reduce waste.
- Vivira — Vivira Health Lab focuses on making physical rehab programs available to everyone.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 46
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
MediVentures is an investment firm.
Show more...Investment focus
- Industry: Wellness, Health Care, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Seed $2.3M–$3.6M; Series A $4.2M–$17M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Brainjo — Brainjo is a digital health company that develops virtual reality–based applications designed to support mental health and cognitive training through immersive experiences. The company’s platform focuses on evidence-based therapies and uses gamification techniques to improve user engagement and adherence to treatment programs. Its solutions includevirtual reality training tools that combine cognitive exercises with physical activity, enabling users to train memory, coordination, and problem-solving skills within interactive environments. Brainjo is also involved in developing digital therapeutics, including applications for conditions such as ADHD, which are intended to complement traditional therapy and may be integrated into healthcare systems. The company collaborates with healthcare experts, researchers, and industry partners to translate scientific insights into practical therapeutic applications delivered through its virtual reality platform.
- XO Life — XO-Life.com is an online destination center. That provides services includes digital treatment monitoring and patient feedback R&D, marketing and sales. That offers services for Patient Insights, information exchange between patients and pharma, treatments and indications.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 188
- Round size: Series A $10M–$83M; Series B $14M–$83M; Private Equity $112M–$237M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fresh fund, raised $491M in 2026
Portfolio highlights
- Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Health Care VC funding in Germany at a glance
Stats across 2.2k deals from 1.7k investors.
Access all 1712 VC funds in Germany Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1712 VC funds investing in Germany Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!